{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T22:57:43Z","timestamp":1789167463704,"version":"build-2803163510"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019000","name":"Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MAB-112-101"],"award-info":[{"award-number":["MAB-112-101"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019000","name":"Medical Affairs Bureau","doi-asserted-by":"publisher","award":["MAB-113-145"],"award-info":[{"award-number":["MAB-113-145"]}],"id":[{"id":"10.13039\/501100019000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-016-004-MY2"],"award-info":[{"award-number":["112-2314-B-016-004-MY2"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejphar.2025.178348","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T02:18:45Z","timestamp":1762481925000},"page":"178348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["NKCC1 inhibition as a breakthrough in combating coagulopathy and boosting survival in LPS-induced DIC rat model"],"prefix":"10.1016","volume":"1008","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6455-3032","authenticated-orcid":false,"given":"Hao-Yuan","family":"Hung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chin","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Hui","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiu-Jen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsieh-Chou","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6534-4304","authenticated-orcid":false,"given":"Chin-Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2025.178348_bib1","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1097\/01.CCM.0000220051.19432.05","article-title":"Do coagulation abnormalities contribute to sepsis associated organ failure?","volume":"34","author":"Abraham","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib2","first-page":"52","article-title":"Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications","volume":"27","author":"Aderka","year":"1991","journal-title":"Isr. J. Med. Sci."},{"key":"10.1016\/j.ejphar.2025.178348_bib3","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0742-8413(91)90053-V","article-title":"Furosemide kinetics and dynamics in rats and humans","volume":"100","author":"Andreasen","year":"1991","journal-title":"Comp. Biochem. Physiol. C Comp. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2025.178348_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/2052-0492-2-20","article-title":"Classifying types of disseminated intravascular coagulation: clinical and animal models","volume":"2","author":"Asakura","year":"2014","journal-title":"J. Intensive Care"},{"key":"10.1016\/j.ejphar.2025.178348_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/01.mbc.0000061290.28953.57","article-title":"Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats","volume":"14","author":"Asakura","year":"2003","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"10.1016\/j.ejphar.2025.178348_bib6","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1097\/01.CCM.0000147769.07699.E3","article-title":"Prospective validation of the international society of thrombosis and haemostasis scoring system for disseminated intravascular coagulation","volume":"32","author":"Bakhtiari","year":"2004","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thromres.2010.12.002","article-title":"Animal models of DIC and their relevance to human DIC: a systematic review","volume":"128","author":"Berthelsen","year":"2011","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2025.178348_bib8","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/bmj.312.7033.770","article-title":"Transforming data","volume":"312","author":"Bland","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2025.178348_bib9","doi-asserted-by":"crossref","first-page":"F991","DOI":"10.1152\/ajprenal.00432.2014","article-title":"Physiology and pathophysiology of the renal Na-K-2Cl cotransporter (NKCC2)","volume":"307","author":"Castrop","year":"2014","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2025.178348_bib10","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1345\/aph.1P605","article-title":"Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin","volume":"45","author":"Chapman","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejphar.2025.178348_bib11","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.tim.2011.01.001","article-title":"Cecal ligation and puncture: the gold standard model for polymicrobial sepsis?","volume":"19","author":"Dejager","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.ejphar.2025.178348_bib12","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1111\/j.1538-7836.2004.00955.x","article-title":"Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation","volume":"2","author":"Dhainaut","year":"2004","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2025.178348_bib13","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/SHK.0b013e3181c0f068","article-title":"Sepsis, leukocytes, and nitric oxide (NO): an intricate affair","volume":"33","author":"Fortin","year":"2010","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2025.178348_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2016.37","article-title":"Disseminated intravascular coagulation","volume":"2","author":"Gando","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ejphar.2025.178348_bib15","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1172\/JCI116151","article-title":"Oxidation of a specific methionine in thrombomodulin by activated neutrophil products blocks cofactor activity. A potential rapid mechanism for modulation of coagulation","volume":"90","author":"Glaser","year":"1992","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ejphar.2025.178348_bib16","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm0196-35","article-title":"Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion","volume":"2","author":"Golino","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib17","series-title":"Disorders of Hemostasis & Thrombosis: a Clinical Guide","author":"Goodnight","year":"2001"},{"key":"10.1016\/j.ejphar.2025.178348_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0022-3565(24)29364-2","article-title":"Pharmacokinetics, pharmacodynamics, and platelet binding of an anti-glycoprotein IIb\/IIIa monoclonal antibody (7E3) in the rat: a quantitative rat model of immune thrombocytopenic purpura","volume":"298","author":"Hansen","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejphar.2025.178348_bib19","doi-asserted-by":"crossref","first-page":"F958","DOI":"10.1152\/ajprenal.00476.2015","article-title":"Everything we always wanted to know about furosemide but were afraid to ask","volume":"310","author":"Huang","year":"2016","journal-title":"Am. J. Physiol. Ren. Physiol."},{"key":"10.1016\/j.ejphar.2025.178348_bib20","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12959-023-00556-6","article-title":"The antithrombin activity recovery after substitution therapy is associated with improved 28-day mortality in patients with sepsis-associated disseminated intravascular coagulation","volume":"21","author":"Iba","year":"2023","journal-title":"Thromb. J."},{"key":"10.1016\/j.ejphar.2025.178348_bib21","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/cc13190","article-title":"Combination of thrombin-antithrombin complex, plasminogen activator inhibitor-1, and protein C activity for early identification of severe coagulopathy in initial phase of sepsis: a prospective observational study","volume":"18","author":"Koyama","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2025.178348_bib22","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0024-3205(03)00382-5","article-title":"In vivo and in vitro antioxidant properties of furosemide","volume":"73","author":"Lahet","year":"2003","journal-title":"Life Sci."},{"key":"10.1016\/j.ejphar.2025.178348_bib23","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00134-009-1723-x","article-title":"Histopathology of septic shock induced acute kidney injury: apoptosis and leukocytic infiltration","volume":"36","author":"Lerolle","year":"2010","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib24","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1056\/NEJM199908193410807","article-title":"Disseminated intravascular coagulation","volume":"341","author":"Levi","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib25","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2016.11.007","article-title":"Coagulation and sepsis","volume":"149","author":"Levi","year":"2017","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2025.178348_bib26","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1097\/CCM.0000000000004426","article-title":"Effect of a recombinant human soluble thrombomodulin on baseline coagulation biomarker levels and mortality outcome in patients with sepsis-associated coagulopathy","volume":"48","author":"Levi","year":"2020","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/sur.2016.021","article-title":"Current murine models of sepsis","volume":"17","author":"Lewis","year":"2016","journal-title":"Surg. Infect."},{"key":"10.1016\/j.ejphar.2025.178348_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s00424-013-1370-5","article-title":"Physiology and pathophysiology of SLC12A1\/2 transporters","volume":"466","author":"Markadieu","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ejphar.2025.178348_bib29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nm0707-780","article-title":"Pulmonary barriers to pneumonia and sepsis","volume":"13","author":"Matthay","year":"2007","journal-title":"Nat. Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib30","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/MNH.0b013e3283484b06","article-title":"Role of SPAK and OSR1 signalling in the regulation of NaCl cotransporters","volume":"20","author":"Mercier-Zuber","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.ejphar.2025.178348_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1755-5922.2009.00080.x","article-title":"Performing repeated noninvasive bedside measures of volume response to intravenous furosemide in acute pulmonary edema: a feasibility assessment","volume":"27","author":"Ng Kam Chuen","year":"2009","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.ejphar.2025.178348_bib32","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1084\/jem.20061205","article-title":"Mice lacking NKCC1 are protected from development of bacteremia and hypothermic sepsis secondary to bacterial pneumonia","volume":"204","author":"Nguyen","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40560-016-0149-0","article-title":"Sepsis and disseminated intravascular coagulation","volume":"4","author":"Okamoto","year":"2016","journal-title":"J. Intensive Care"},{"key":"10.1016\/j.ejphar.2025.178348_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/SHK.0000000000001212","article-title":"Minimum quality threshold in pre-clinical sepsis studies (MQTiPSS): an international expert consensus initiative for improvement of animal modeling in sepsis","volume":"50","author":"Osuchowski","year":"2018","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2025.178348_bib35","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nprot.2008.214","article-title":"Immunodesign of experimental sepsis by cecal ligation and puncture","volume":"4","author":"Rittirsch","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejphar.2025.178348_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1615\/CritRevImmunol.2015015461","article-title":"Pathogenesis of multiple organ failure in sepsis","volume":"35","author":"Rossaint","year":"2015","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.ejphar.2025.178348_bib37","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1056\/NEJMra043632","article-title":"Management of sepsis","volume":"355","author":"Russell","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0049-3848(93)90174-M","article-title":"Fibrin-specific lysis of microthrombosis in endotoxemic rats by saruplase","volume":"72","author":"Schneider","year":"1993","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ejphar.2025.178348_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1751-7176.2011.00512.x","article-title":"Thiazide and loop diuretics","volume":"13","author":"Sica","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"10.1016\/j.ejphar.2025.178348_bib40","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1160\/TH15-09-0740","article-title":"Supportive management strategies for disseminated intravascular coagulation","volume":"115","author":"Squizzato","year":"2016","journal-title":"Int. Consensus Thromb Haemost"},{"key":"10.1016\/j.ejphar.2025.178348_bib41","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13063-023-07853-5","article-title":"Efficacy and safety of heparin for sepsis-induced disseminated intravascular coagulation (HepSIC): study protocol for a multicenter randomized controlled trial","volume":"25","author":"Sun","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.ejphar.2025.178348_bib42","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1055\/s-0037-1616068","article-title":"Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation","volume":"86","author":"Taylor","year":"2001","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2025.178348_bib43","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0037-1615901","article-title":"The pathophysiology of disseminated intravascular coagulation","volume":"82","author":"ten Cate","year":"1999","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2025.178348_bib44","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00268-006-0653-9","article-title":"Coagulopathy: its pathophysiology and treatment in the injured patient","volume":"31","author":"Tieu","year":"2007","journal-title":"World J. Surg."},{"key":"10.1016\/j.ejphar.2025.178348_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1186\/s13054-018-2210-y","article-title":"Angiotensin-(1-7) attenuates organ injury and mortality in rats with polymicrobial sepsis","volume":"22","author":"Tsai","year":"2018","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2025.178348_bib46","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00134-010-1839-z","article-title":"Effects of terbutaline on circulatory failure and organ dysfunction induced by peritonitis in rats","volume":"36","author":"Tsao","year":"2010","journal-title":"Intensive Care Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib47","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/00024382-200405000-00014","article-title":"Low-dose dexamethasone ameliorates circulatory failure and renal dysfunction in conscious rats with endotoxemia","volume":"21","author":"Tsao","year":"2004","journal-title":"Shock"},{"key":"10.1016\/j.ejphar.2025.178348_bib48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1097\/CCM.0B013E318165395E","article-title":"Combined effects of propofol and dexamethasone on rats with endotoxemia","volume":"36","author":"Tsao","year":"2008","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib49","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1186\/s13054-014-0652-4","article-title":"Levosimendan attenuates multiple organ injury and improves survival in peritonitis-induced septic shock: studies in a rat model","volume":"18","author":"Tsao","year":"2014","journal-title":"Crit. Care"},{"key":"10.1016\/j.ejphar.2025.178348_bib50","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1002\/hep4.1794","article-title":"Definition of healthy ranges for alanine aminotransferase levels: a 2021 update","volume":"5","author":"Valenti","year":"2021","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ejphar.2025.178348_bib51","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/jth.14812","article-title":"Efficacy and safety of recombinant human soluble thrombomodulin in patients with sepsis-associated coagulopathy: a systematic review and meta-analysis","volume":"18","author":"Valeriani","year":"2020","journal-title":"J. Thromb. Haemostasis"},{"key":"10.1016\/j.ejphar.2025.178348_bib52","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1084\/jem.179.4.1253","article-title":"Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees","volume":"179","author":"van der Poll","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib53","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/jth.12155","article-title":"Guidance for diagnosis and treatment of DIC from harmonization of the recommendations from three guidelines","volume":"11","author":"Wada","year":"2013","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ejphar.2025.178348_bib54","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1111\/j.1365-2222.2011.03811.x","article-title":"Effects of furosemide on allergic asthmatic responses in mice","volume":"41","author":"Wang","year":"2011","journal-title":"Clin. Exp. Allergy"},{"key":"10.1016\/j.ejphar.2025.178348_bib55","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1001\/jama.286.15.1869","article-title":"Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial","volume":"286","author":"Warren","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2025.178348_bib56","doi-asserted-by":"crossref","first-page":"393","DOI":"10.3389\/fimmu.2017.00393","article-title":"Cytokine-regulation of Na(+)-K(+)-Cl(-) cotransporter 1 and cystic fibrosis transmembrane conductance regulator-potential role in pulmonary inflammation and edema formation","volume":"8","author":"Weidenfeld","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2025.178348_bib57","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/00045632211050531","article-title":"Best practice in statistics: the use of log transformation","volume":"59","author":"West","year":"2022","journal-title":"Ann. Clin. Biochem."},{"key":"10.1016\/j.ejphar.2025.178348_bib58","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation\/American heart association task force on practice guidelines","volume":"128","author":"Writing Committee","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2025.178348_bib59","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/jcp.21495","article-title":"iNOS expression requires NADPH oxidase-dependent redox signaling in microvascular endothelial cells","volume":"217","author":"Wu","year":"2008","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.ejphar.2025.178348_bib60","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1681\/ASN.2009121295","article-title":"SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction","volume":"21","author":"Yang","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ejphar.2025.178348_bib61","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1097\/01.CCM.0000198530.68343.21","article-title":"Propofol improves endothelial dysfunction and attenuates vascular superoxide production in septic rats","volume":"34","author":"Yu","year":"2006","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ejphar.2025.178348_bib62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1081-1206(10)62870-0","article-title":"Immunosuppressive and cytotoxic effects of furosemide on human peripheral blood mononuclear cells","volume":"83","author":"Yuengsrigul","year":"1999","journal-title":"Ann. Allergy Asthma Immunol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299925011021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:59:40Z","timestamp":1777402780000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299925011021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":62,"alternative-id":["S0014299925011021"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178348","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NKCC1 inhibition as a breakthrough in combating coagulopathy and boosting survival in LPS-induced DIC rat model","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2025.178348","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"178348"}}